VASODILATORS AND THE TREATMENT OF ANGINA Flashcards
Variant Angina (aka Angiospastic Angina)
● oxygen delivery decreases as a result of reversible coronary vasospasm
Classic Angina (aka Angina of Effort)
● myocardial oxygen requirement increases (as during exercise), but coronary blood flow does not increase proportionally, usually due to atheromatous obstruction of coronary vessels.
Unstable Angina (aka Acute Coronary Syndrome)
● characterized by the progression of stable angina to repeated episodes, even at rest
●usually due to atherosclerotic plaque rupture
●very often a precursor of acute myocardial infarction
Goals of Therapy for angina
● increase the delivery of oxygen to cardiac tissue by increasing coronary blood flow
and/or
● decrease oxygen demand by decreasing cardiac work
● for angina of effort, pharmacological interventions usually only decrease
cardiac work through systemic vasodilation
● for variant angina, pharmacological agents can be used to reverse coronary vasospasm
PATHOPHYSIOLOGY OF ANGINA
Determinants of Myocardial Oxygen Demand
- heart rate
- cardiac contractility
- arterial pressure
- ventricular volume
PATHOPHYSIOLOGY OF ANGINA
Determinants of Coronary Blood Flow
- aortic diastolic pressure
- duration of diastole
- coronary vascular bed resistance
PATHOPHYSIOLOGY OF ANGINA
Determinants of Vascular Tone
- ateriolar and venous tone play a role in peripheral vascular resistance and
arterial blood pressure
PATHOPHYSIOLOGY OF ANGINA
Ways to Relax Vascular Smooth Muscle
● increase cGMP: cGMP facilitates dephosphorylation of myosin light chain,preventing myosin’s interaction with actin
example: organic nitrates (nitroglycerin, etc.)
●decreasing intracellular Ca++ by preventing Ca++ entry: reduces activity of myosin light chain kinase
example: Ca++ channel blockers (verapamil, diltiazem,
● stabilizing or preventing depolarization of membrane potential by increasing K+permeability: prevents activation of voltage-gated Ca++ channels
example: K+ channel openers (e.g., minoxidil, hydralazine)
●increase cAMP: cAMP increases the rate of inactivation of myosin light chain kinase (NOTE: THESE AGENTS ARE NOT USED IN THE TREATMENT OF ANGINA DUE TO EFFECTS ON HEART RATE AND CONTRACTILITY!!)
ORGANIC NITRATES
● these agents release nitric oxide (NO) at target tissues
● released NO activates guanylate cyclase, which leads to an elevation cGMPcontent
● at therapeutic doses, their action is largely confined to smooth muscle
● however, the main effect of NO in terms of angina is venodilation, which reduces preload and ventricular filling, which in turn reduces myocardial O2 demand.
● dilation of large coronary arteries and arterioles leads to a redistribution of
blood flow from epicardial to endocardial regions, providing some relief from ischemia